

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | VBIT-4 inhibits the oligomerization of voltage-dependent anion channel 1 (VDAC1) with a binding affinity (Kd) of 17 μM. As an inhibitor of apoptosis, it has potential therapeutic applications in conditions associated with apoptosis, including neurodegenerative and cardiovascular diseases [1]. |
| 体外研究 | VBIT-4 acts on the mitochondrial protein VDAC1 to prevent apoptosis and safeguard against mitochondrial dysfunction. At concentrations of 0.1-10 μM, VBIT-4 (0.1-10 μM) blocks VDAC1 oligomerization, Cyto-C release from mitochondria, and apoptosis in HEK-293 cells, with IC50 values of 1.9±0.08 μM, 1.8±0.24 μM, and 2.9±0.12 μM, respectively [1]. |
| Concentration | Treated Time | Description | References | |
| HeLa cells | 10 µM | 1 hour | VBIT-4 suppressed the release of mtDNA caused by Phb1 knockdown | EMBO J. 2022 Dec 15;41(24):e111173. |
| J774A.1 cells | 10 µM | 1 hour | VBIT-4 suppressed the release of mtDNA caused by Phb1 knockdown | EMBO J. 2022 Dec 15;41(24):e111173. |
| NSC-34 cells | 15 µM | 12 hours | VBIT-12 partially prevented the mutant SOD1-induced cell toxicity | Int J Mol Sci. 2022 Sep 1;23(17):9946. |
| Mouse lung endothelial cells | 5 µM | 36 hours | VBIT-4 prevented hyperglycemia-induced cell death and mitochondrial dysfunction, inhibiting spontaneous MPT pore opening and ROS generation. | Antioxidants (Basel). 2023 Jul 20;12(7):1459. |
| Rat cortical neurons | 10 µM | 6, 24, 48 hours | VBIT-4 prevented Aβ-induced VDAC1 overexpression and apoptotic cell death | Transl Neurodegener. 2022 Dec 28;11(1):58. |
| Endog−/− MEFs | 10 µM | VBIT-4 decreased cmtDNA levels and ISG expression | Science. 2019 Dec 20;366(6472):1531-1536. | |
| MDA231 | 10 µM | VBIT-4 induces VDAC1 monomerization and promotes PRKN-mediated polyubiquitination | Autophagy. 2023 Sep;19(9):2443-2463. | |
| MDA468 | 10 µM | VBIT-4 induces VDAC1 monomerization and promotes PRKN-mediated polyubiquitination | Autophagy. 2023 Sep;19(9):2443-2463. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | MpJ- Faslpr lupus-prone mice | 10 μM | VBIT-4 ameliorated lupus-like symptoms, including the reduction of skin lesions, renal immune complex deposition, proteinuria, anti-dsDNA antibody, antinuclear antibody, IgG, and cell-free mtDNA levels | Science. 2019 Dec 20;366(6472):1531-1536. | ||
| Mice | 5 × FAD mouse model | Drinking water | 20 mg/kg | Twice a week for 5 months | VBIT-4 prevented cognitive decline, neuronal loss, neuroinflammation, and neuro-metabolic dysfunctions | Transl Neurodegener. 2022 Dec 28;11(1):58. |
| C57BL/6 mice | DSS-induced colitis model | Drinking water | 20 mg/kg | From day 2 or day 5 until day 14 | VBIT-12 significantly alleviated DSS-induced colitis pathology, inhibited inflammatory cell infiltration, apoptosis, mtDNA release, and NLRP3 inflammasome activation, and reduced the inflammatory response | Mol Ther. 2022 Feb 2;30(2):726-744 |
| Mice | SOD1G93A mutant mice | Intraperitoneal injection | 26 mg/kg | Every other day for 12 weeks | VBIT-12 significantly improved muscle endurance in SOD1G93A mutant mice | Int J Mol Sci. 2022 Sep 1;23(17):9946. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.18mL 0.44mL 0.22mL |
10.92mL 2.18mL 1.09mL |
21.84mL 4.37mL 2.18mL |
|
| CAS号 | 2086257-77-2 |
| 分子式 | C21H23ClF3N3O3 |
| 分子量 | 457.87 |
| SMILES Code | O=C(CC(CO)N1CCN(CC1)C2=CC=C(C=C2)OC(F)(F)F)NC3=CC=C(C=C3)Cl |
| MDL No. | MFCD32663268 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | QYSQXVAEFPWMEM-UHFFFAOYSA-N |
| Pubchem ID | 126697666 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,Store in freezer, under -20°C |
| 溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1